Modelling the impact of reopening schools in early 2021 in the presence of the new SARS-CoV-2 variant and with roll-out of vaccination against COVID-19
View ORCID ProfileJ. Panovska-Griffiths, R.M. Stuart, C.C. Kerr, K. Rosenfield, D. Mistry, W. Waites, D.J. Klein, C. Bonell, View ORCID ProfileR.M. Viner
doi: https://doi.org/10.1101/2021.02.07.21251287
J. Panovska-Griffiths
1Department of Applied Health Research, University College London, London, UK
2Institute for Global Health, University College London, London, UK
3The Wolfson Centre for Mathematical Biology and The Queen’s College, Oxford University, Oxford, UK
R.M. Stuart
4Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia
5Department of Mathematical Sciences, University of Copenhagen, Copenhagen, Denmark
C.C. Kerr
6Institute for Disease Modeling, Global Health Division, Bill & Melinda Gates Foundation, Seattle, USA
7School of Physics, University of Sydney, Sydney, NSW, Australia
K. Rosenfield
6Institute for Disease Modeling, Global Health Division, Bill & Melinda Gates Foundation, Seattle, USA
D. Mistry
6Institute for Disease Modeling, Global Health Division, Bill & Melinda Gates Foundation, Seattle, USA
W. Waites
8School of Informatics, University of Edinburgh, UK
9Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, Keppel St, London, UK
D.J. Klein
6Institute for Disease Modeling, Global Health Division, Bill & Melinda Gates Foundation, Seattle, USA
C. Bonell
10Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK
R.M. Viner
11UCL Great Ormond St. Institute of Child Health, London, UK
Data Availability
All data and numerical code used in this analysis are available at https://github.com/Jasminapg/Covid-19-Analysis
Posted February 09, 2021.
Modelling the impact of reopening schools in early 2021 in the presence of the new SARS-CoV-2 variant and with roll-out of vaccination against COVID-19
J. Panovska-Griffiths, R.M. Stuart, C.C. Kerr, K. Rosenfield, D. Mistry, W. Waites, D.J. Klein, C. Bonell, R.M. Viner
medRxiv 2021.02.07.21251287; doi: https://doi.org/10.1101/2021.02.07.21251287
Modelling the impact of reopening schools in early 2021 in the presence of the new SARS-CoV-2 variant and with roll-out of vaccination against COVID-19
J. Panovska-Griffiths, R.M. Stuart, C.C. Kerr, K. Rosenfield, D. Mistry, W. Waites, D.J. Klein, C. Bonell, R.M. Viner
medRxiv 2021.02.07.21251287; doi: https://doi.org/10.1101/2021.02.07.21251287
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)